Skip to main content
STARSOURCE MULTITRADE LIMITED logo

STARSOURCE MULTITRADE LIMITED — Investor Relations & Filings

Ticker · 506365 ISIN · INE320M01019 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 319 across all filing types
Latest filing 2023-07-31 Earnings Release
Country IN India
Listing BSE.NS 506365

About STARSOURCE MULTITRADE LIMITED

https://starsourcemultitrade.com/

STARSOURCE MULTITRADE LIMITED is a commercial entity engaged in the wholesale distribution and trading of a broad range of products. The organization primarily focuses on the procurement, supply, and logistics of textiles, fabrics, and related materials. Its core operations involve managing complex supply chains to connect manufacturers with diverse market segments. The company prioritizes the sourcing of high-quality goods and maintains a robust distribution network to ensure efficient delivery and market responsiveness. By focusing on bulk trading and strategic sourcing, the firm serves as a key intermediary in the movement of materials across various commercial channels.

Recent filings

Filing Released Lang Actions
Submission of Newspaper Advertisement of Unaudited Financial Results for the Quarter Ended June 30, 2023
Earnings Release Classification · 90% confidence The document is a submission to the Bombay Stock Exchange regarding the newspaper advertisement of unaudited financial results for the quarter ended June 30, 2023. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of financial results. The document includes details about the advertisement publication dates and mentions that the results will be posted on the company's website. The content is primarily an announcement of the publication of the unaudited quarterly financial results, not the full financial report itself. The document length is 15,000 characters, but the content is focused on the announcement of the results advertisement rather than the detailed financial statements or analysis. Therefore, this fits best under the category of Earnings Release (ER), which covers initial announcements of quarterly financial results with key highlights, rather than a full Interim/Quarterly Report (IR) which would contain detailed financial statements and analysis.
2023-07-31 English
Intimation of Book Closure Pursuant to the Regulation 42(2) to 4 of SEBI (LODR) Regulations, 2015
Regulatory Filings
2023-07-27 English
Approval of Un-Audited Financial Results of the Company for the Quarter Ended June 30, 2023 along with the Limited Review Report thereon.
Regulatory Filings
2023-07-27 English
1. Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2023 along with the Limited Review Report thereon. 2. Approval of the Notice of the ....
Regulatory Filings
2023-07-27 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 ,inter alia, to consider and approve 1. the Un-Audited ....
Regulatory Filings
2023-07-14 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulation, 2015
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the Bombay Stock Exchange regarding the issuance of duplicate share certificates due to loss of original certificates. It references Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, which pertains to share certificate management. The content is about a specific shareholder's request and the company's compliance with regulatory requirements. There is no financial data, earnings information, management discussion, or report attached or referenced. The document is an announcement related to share certificates, which falls under capital changes but specifically concerns duplicate share certificates rather than new share issues or capital restructuring. This type of communication is best classified under Regulatory Filings (RNS) as it is a regulatory compliance announcement that does not fit other more specific categories like Share Issue/Capital Change or Director's Dealing.
2023-07-14 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.